Open Access

Expression of CD24 and B7-H3 in breast cancer and the clinical significance

  • Authors:
    • Fang Cong
    • Haitao Yu
    • Xiuhua Gao
  • View Affiliations

  • Published online on: October 5, 2017     https://doi.org/10.3892/ol.2017.7142
  • Pages:7185-7190
  • Copyright: © Cong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: PDF 0 views | HTML 0 views
0

Abstract

This study aimed to investigate the correlation between the expression of CD24 and B7-H3 in breast cancer tissues and the clinical significance. Expression of CD24 and B7-H3 in breast cancer and adjacent tissues were detected by immunohistochemistry. Quantitative PCR was used to detect the expression of CD24 and B7-H3 mRNA in breast cancer and adjacent tissues. The expression of CD24 and B7-H3 protein in breast cancer and adjacent tissues was detected by immunoblotting. The correlation between the expression levels of the two proteins was analyzed and the relationship between the expression of two proteins and the 5-year survival of breast cancer patients was investigated. CD24 and B7-H3 were positively expressed in breast cancer and adjacent tissues, the CD24-positive rate was 75.7 and 25.7%, respectively, and the B7-H3-positive rate was 56.8 and 43.2%, respectively, and the differences were statistically significant (P<0.05). The expression of CD24 was positively correlated with the expression of B7-H3 (Spearman's correlation coefficient r, 0.297; p=0.036). The positive and negative expression of CD24 and B7-H3 significantly affected the 5-year survival of breast cancer patients (P<0.05). Quantitative PCR results showed that the expression levels of CD24 and B7-H3 mRNA in breast cancer tissues were significantly higher than those in adjacent tissues (P<0.05). The expression levels of CD24 and B7-H3 protein in breast cancer tissues were also significantly higher than those in adjacent tissues (P<0.05). CD24 and B7-H3 were highly expressed in breast cancer, suggesting that both CD24 and B7-H3 were related to the development of breast cancer. Five-year survival analysis of breast cancer patients showed that the high expression of CD24 and B7-H3 were correlated with the poor prognosis of patients. Thus, CD24 and B7-H3 may become new targets for the treatment of breast cancer.

Related Articles

Journal Cover

December 2017
Volume 14 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Cong, F., Yu, H., & Gao, X. (2017). Expression of CD24 and B7-H3 in breast cancer and the clinical significance. Oncology Letters, 14, 7185-7190. https://doi.org/10.3892/ol.2017.7142
MLA
Cong, F., Yu, H., Gao, X."Expression of CD24 and B7-H3 in breast cancer and the clinical significance". Oncology Letters 14.6 (2017): 7185-7190.
Chicago
Cong, F., Yu, H., Gao, X."Expression of CD24 and B7-H3 in breast cancer and the clinical significance". Oncology Letters 14, no. 6 (2017): 7185-7190. https://doi.org/10.3892/ol.2017.7142